Clinician Scientist
Head, Pharmacogenetics Research Clinic, Campbell Family Mental Health Research Institute, CAMH
Optimizing pharmacological treatment for mood disorders and schizophrenia by:
1) taking into account gene-drug pairs affecting medication plasma levels, response and adverse effects with psychotropic medications (pharmacogenomics)
2) developing and implementing pharmacogenetic-based algorithms in clinical practice (see Pharmacogenetic Research Clinic at CAMH, https://PGxRC.ca)
3) investigating the causal role of the gut-brain axis of medication effects and testing interventions with probiotics to alleviate mood symptoms
Publications: Author/Co-Author on more than 250 peer-reviewed scientific journals.
http://scholar.google.ca/citations?user=lnbto4AAAAAJ&hl=en
